Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Meunier

Showing results (401-410 of 411) with videos related to

Pageof 42
Sort By:
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 23, 2007
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosisJ P Devogelaer, J P Brown, P Burckhardt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 9, 2005
Predictive value of BMD for hip and other fracturesOlof Johnell, John A Kanis, Anders Oden, et al.
Regional Anesthesia and Pain Medicine|February 17, 2019
Ultrasound-guided percutaneous peripheral nerve stimulation: neuromodulation of the suprascapular nerve and brachial plexus for postoperative analgesia following ambulatory rotator cuff repair. A proof-of-concept studyBrian M Ilfeld, John J Finneran, Rodney A Gabriel, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2000
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study GroupH G Bone, S L Greenspan, C McKeever, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2005
Body mass index as a predictor of fracture risk: a meta-analysisC De Laet, J A Kanis, A Odén, et al.
The New England Journal of Medicine|July 6, 2012
A pooled analysis of vitamin D dose requirements for fracture preventionHeike A Bischoff-Ferrari, Walter C Willett, Endel J Orav, et al.
British Journal of Cancer|January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO groupP-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
Gynecologic Oncology|September 15, 2019
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancerI Vergote, A du Bois, A Floquet, et al.
Seminars in Arthritis and Rheumatism|June 1, 1996
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical DensitometryP D Miller, S L Bonnick, C J Rosen, et al.
Bone|February 1, 1996
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisJ P Devogelaer, H Broll, R Correa-Rotter, et al.
Pageof 42

Showing results (401-410 of 411) with videos related to

Sort By:
Pageof 42
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 23, 2007
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosisJ P Devogelaer, J P Brown, P Burckhardt, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 9, 2005
Predictive value of BMD for hip and other fracturesOlof Johnell, John A Kanis, Anders Oden, et al.
Regional Anesthesia and Pain Medicine|February 17, 2019
Ultrasound-guided percutaneous peripheral nerve stimulation: neuromodulation of the suprascapular nerve and brachial plexus for postoperative analgesia following ambulatory rotator cuff repair. A proof-of-concept studyBrian M Ilfeld, John J Finneran, Rodney A Gabriel, et al.
The Journal of Clinical Endocrinology and Metabolism|February 26, 2000
Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study GroupH G Bone, S L Greenspan, C McKeever, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2005
Body mass index as a predictor of fracture risk: a meta-analysisC De Laet, J A Kanis, A Odén, et al.
The New England Journal of Medicine|July 6, 2012
A pooled analysis of vitamin D dose requirements for fracture preventionHeike A Bischoff-Ferrari, Walter C Willett, Endel J Orav, et al.
British Journal of Cancer|January 11, 2017
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO groupP-E Heudel, M Fabbro, C Roemer-Becuwe, et al.
Gynecologic Oncology|September 15, 2019
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancerI Vergote, A du Bois, A Floquet, et al.
Seminars in Arthritis and Rheumatism|June 1, 1996
Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical DensitometryP D Miller, S L Bonnick, C J Rosen, et al.
Bone|February 1, 1996
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosisJ P Devogelaer, H Broll, R Correa-Rotter, et al.
Pageof 42